Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when ALTO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsAlto Ingredients establishes up to $50M at-the-market equity offering program
Filed August 7, 2026 · Period ending August 5, 2026 · ~1 min read
Key Changes
-
high
Company entered into agreement with three broker-dealers to sell up to $50 million of common stock on an as-needed basis through at-the-market offerings, providing flexible capital access without traditional underwriting.
Item 1.01 verify on EDGAR → -
medium
Proceeds will be used for general corporate purposes including working capital and capital expenditures; company controls timing and volume of any sales and is not obligated to sell shares.
Item 1.01 verify on EDGAR → -
low
Item 1.01 verify on EDGAR →
Summary
Alto Ingredients has established an at-the-market equity offering program that allows the company to raise up to $50 million by selling common stock through three broker-dealers on an as-needed basis. Unlike a traditional underwritten offering, this ATM program gives management discretion over the timing, pricing, and volume of any stock sales, with no obligation to sell any shares. The company will pay a 3.0% commission on proceeds and plans to use any capital raised for general corporate purposes including working capital and capital expenditures.
For existing shareholders, this represents potential dilution of up to $50 million at the company's discretion. The broad use-of-proceeds language provides management flexibility but offers no visibility into specific deployment plans. The ATM structure is a standard capital-raising tool that allows the company to opportunistically access equity markets when it determines conditions are favorable, rather than committing to a fixed-size offering upfront.
Section-by-Section Diff
Event · Item 1.01 — Entry into a Material Definitive Agreement
Item 1.01 — Entry into a Material Definitive Agreement filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On August 5, 2026, Alto Ingredients, Inc. (the “Company”) entered into an At-The-Market Issuance Sales Agreement (the “Sales Agreement”) with Craig-Hallum Capital Group LLC (the “Designated Agent”), The Benchmark Company, LLC and H.C. Wainwright & Co., LLC (each, an “Agent,” and collectively, the “Agents”). In accordance with the terms of the Sales Agreement, from time-to-time the Company may offer and sell shares of its common stock, $0.001 par value per share (the “Shares”), having an aggregate offering price of up to $50.0 million (the “Offering”), through the Designated Agent acting as designated sales agent and/or to any Agent selected by the Company, acting as principal.
Alto Ingredients established an at-the-market equity offering program allowing the company to sell up to $50 million of common stock through three broker-dealers on an as-needed basis. This provides the company with flexible access to capital markets without the need for a traditional underwritten offering. The company is not obligated to sell any shares and will control the timing, pricing, and volume of any sales.
Added in current filing · verify on EDGAR →
The Company currently intends to use the net proceeds from the Offering, if any, for general corporate purposes, including working capital and capital expenditures.
The company plans to use proceeds from any stock sales for general corporate purposes, including working capital and capital expenditures. This broad use-of-proceeds language gives management flexibility in deploying the capital but does not specify particular projects or initiatives.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
Under the terms of the Sales Agreement, the Company will pay the Agents a commission equal to 3.0% of the aggregate gross proceeds from the Offering. The Company will also reimburse the Agents for certain expenses incurred in connection with the Sales Agreement.
The company will pay a 3.0% commission on gross proceeds to the broker-dealers facilitating the sales, plus reimburse certain expenses. This is a standard commission rate for at-the-market offerings and represents the cost of accessing this capital-raising mechanism.
Added in current filing · verify on EDGAR →
Any Shares offered and sold in the Offering will be issued pursuant to the Company’s effective shelf registration statement on Form S-3 (No. 333-295723) (the “Registration Statement”), which was initially filed with the Securities and Exchange Commission (the “SEC”) on May 8, 2026, and declared effective on May 22, 2026, including the base prospectus contained in the Registration Statement, as supplemented by a prospectus supplement filed with the SEC on August 5, 2026 pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act”).
The stock sales will be made under an existing shelf registration statement that was declared effective in May 2026, with a prospectus supplement filed on August 5, 2026. This confirms the company has the regulatory framework in place to execute the offering immediately.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 10, 2026 · How we verify